| Literature DB >> 32206455 |
Ravi R Pradhan1, Sant K Yadav2, Shreebodh K Yadav3.
Abstract
Guillian-Barre Syndrome (GBS) typically presents as symmetrical ascending flaccid muscle weakness with areflexia, and with or without sensory symptoms. However, some patients may present atypically, and accordingly, different variants of GBS have been reported in the literature. Pharyngeal-cervical-brachial variant is one of the rare variants and is characterized by muscle weakness extending from the oropharyngeal and neck area to the proximal upper extremities. Many physicians and neurologists are unfamiliar about pharyngeal-cervical-brachial variant, which is often misdiagnosed as brainstem stroke, myasthenia gravis or botulism. Herein, we report a case of pharyngeal-cervical-brachial variant of GBS. To the best of our knowledge, this is the first reported case of pharyngeal-cervical-brachial variant of GBS in children from Nepal. A 14-year-old Asian male presented with weakness of bilateral upper limb, dysphagia, and nasal intonation of voice. A diagnosis of pharyngeal-cervical-brachial variant of GBS was made after excluding all other possible differentials and based on cerebrospinal fluid analysis and nerve conduction study. The patient improved following conservative management. Pharyngeal-cervical-brachial variant of GBS should always be considered in any patient presenting with symmetrical upper limb weakness and bulbar palsy. This is to ensure early diagnosis, treatment, and follow-up of the potential complications.Entities:
Keywords: atypical presentation; case report; children; gullian-barre syndrome; pharyngeal-cervical-brachial variant
Year: 2020 PMID: 32206455 PMCID: PMC7077086 DOI: 10.7759/cureus.6983
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Laboratory parameters on admission
| Parameters | Reference range, Children | On admission |
| White-cell count (per mm3) | 4000-12000 | 6700 |
| Diffferential count (%) | ||
| Neutrophils | 40-70 | 70 |
| Lymphocytes | 22-44 | 27 |
| Eosinophils | 0-10 | 2 |
| Monocytes | 4-11 | 1 |
| Hemoglobin (gm/dl) | 12-16 | 13.5 |
| Random blood sugar (mmol/l) | 3.5-7.0 | 3.8 |
| Urea (mmol/l) | 1.6-7.0 | 4.8 |
| Creatinine (mmol/l) | 60-115 | 90 |
| Sodium (mEq/l) | 135-145 | 137 |
| Potassium (mEq/l) | 3.5-5.2 | 4.3 |
| Calcium (mmol/l) | 2.1-2.6 | 2.3 |
| Cerebrospinal fluid analysis | ||
| White-cell count | 0-5 (all lymphocytes) | 5 (all lymphocytes) |
| Glucose (mmol/l) | 2.3-4.6 | 3.1 |
| Protein (mg/dL) | 15-45 | 60 |
| Red blood cell (per mm3) | 0-0 | 0 |
Figure 1Nerve conduction study of motor nerves
A and B: Increased distal and proximal latencies of right common peroneal nerve
C and D: Increased distal and proximal latencies of left common peroneal nerve
Diagnostic criteria for the pharyngeal–cervical–brachial variant of Guillain–Barre syndrome
| Features required for diagnosis | Features strongly supportive of the diagnosis |
| 1. Relatively symmetric oropharyngeal weakness and neck weakness and arm weakness and arm areflexia/ hyporeflexia | 1. Antecedent infectious symptoms |
| 2. Absence of ataxia and disturbed consciousness and prominent leg weakness | 2. Cerebrospinal fluid albuminocytological dissociation |
| 3. Monophasic illness pattern and interval between onset and nadir of oropharyngeal or arm weakness between 12 hours and 28 days and subsequent clinical plateau | 3. Neurophysiological evidence of neuropathy |
| 4. Absence of identified alternative diagnosis | 4. Presence of IgG anti-GT1a or anti-GQ1b antibodies |